![](/img/cover-not-exists.png)
A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)
Strouse, Christopher, Nadiminti, Kalyan, Claus, Jillna, Berns, Gabrielle, Schultz, Allyson, Mott, Sarah L., Vikas, Praveen, Tomasson, Michael, Farooq, Umar, Silverman, Margarida, Jethava, YogeshVolume:
25
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2018.12.793
Date:
March, 2019
File:
PDF, 362 KB
2019